期刊文献+

PPAR-γ配体降低^(137)Cs照射诱导的PAI-1高表达 被引量:1

PPAR-γ ligand in suppressing radiation induced PAI-1 upregulation
原文传递
导出
摘要 目的观察大鼠肾小球膜细胞137Cs照后PAI1基因的表达情况,以及PPARγ配体Pioglitazone对照射诱导的PAI1表达的影响。方法10Gyγ线照射±10mmol/LPioglitazone处理大鼠肾小球膜细胞,用RTPCR方法证明PPARγ基因表达,用Northernblot、Westernblot方法观察PAI1基因表达,用Gelshift方法观察AP1基因的活性变化(由于PAI1基因启动子区存在AP1结合位点,加之AP1介导某些炎性因子的产生且AP1是照射诱导的早期表达基因之一,因此观察照射在大鼠肾小球膜细胞能否诱导AP1活性的升高,并进一步观察Pioglitazone对照后AP1活性的影响)。结果RTPCR方法证明了大鼠肾小球膜细胞表达PPARγ基因。10Gy照后Northernblot结果显示照后24hPAI1mRNA的表达增加,不同剂量照后24hPAI1mRNA的高表达呈照射剂量依赖性。10mmol/LPioglitazone+10Gy照后24h的Northernblot和48h的Westernblot结果表明,Pioglitazone使照射诱导的PAI1基因高表达在mRNA水平和蛋白水平均明显降低。Gelshift结果发现放疗后2hAP1活性开始升高,4h最高,加入Pioglitazone后明显被抑制。结论PPARγ配体Pioglitazone使照射诱导的肾小球膜细胞PAI1基因高表达降低,其机制可能是通过降低AP1活性来调节PAI1的表达。Pioglitazone可能具有预防或降低放射性肾损伤的作用,这将有待于动物实验的进一步证实。 Objective observe the post-radiation expression of rat mesangial cell plasminogen activator inhibitor-1 (PAI-1), and the effect of PPAR-γ ligand on radiation induced PAI-1 expression. Methods After 10?Gy γ-ray radiation of cultured rat kidney mesangial cell, RT-PCR was used to observe PPAR-γexpression. PAI-1 expression after 10?Gy radiation ±10?mmol/L pioglitazone (one of PPAR-γ ligands) was measured by Northern blot and Western blot. Gel-shift method was used to study the effect of AP-1 of PPAR-γ ligand on radiation induced PAI-1 expression. Methods Rat kidney mesangial cell expressed PPAR--γ mRNA. PAI-1 over-expressed at 24 hour after 10?Gy radiation in a radiation dose dependent manner, but not at other time. When the cell was treated with 10?Gy + 10?mmol/L pioglitazone, PAI-1 upregulation was blunted at message and protein level. AP-1 activation was increased from the 2nd hour after 10?Gy radiation and reached the highest level at the 4th hour. When pioglitazone was added, the radiation induced increase in AP-1 activation was suppressed at the 4th hour. Conclusions Pioglitazone, mediated by AP-1 gene, can suppress radiation induced PAI-1 upregulation.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2005年第4期357-361,共5页 Chinese Journal of Radiation Oncology
关键词 PPAR-Γ配体 137Cs照射 诱导作用 PAI-1表达 肾小球 PPAR-γ ligand PAI-1 gene Glomerular mesangial cell line Irradiation
  • 相关文献

参考文献9

  • 1Ma LJ, Marcantoni C, Linton MF, et al. Peroxisome proliferator-activated receptor-ga mmol/La agonist troglitazone protects against nondiabetic glomerulo-sclerosis in rats. Kidney Int, 2001,59:1899-1910.
  • 2Kitching AR, Kong YZ, Huang XR, et al. Plasminogen Activator Inhibitor-1 Is a Significant Determinant of Renal Injury in Experimental Crescentic Glomerulonephritis. J Am Soc Nephrol, 2003,14:1487-1495.
  • 3Isshiki K, Haneda M, Koya D,et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes,2000,49:1022-1032.
  • 4Zheng F,Fomoni A,Elliot SJ,et al. Upregulation of type Ⅰ collagen by TGF-β in mesangial cells is blocked by PPAR-γactivation. Am J Physiol(Renal Physiol),2002,282: F639-F648.
  • 5Nicholas SB, Kawano Y, Wakino S, et al. Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells. Hypertension,2001,37: 722-727.
  • 6Marx N, Bourcier T,Sukhova GK, et al. PPAR-γactivation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR-γas a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol, 1999,19:546-551.
  • 7Rerolle JP, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type-1 is a potential target in renal fibrogenesis. Kidney Int, 2000, 58:1841-1850.
  • 8Gelman L, Fruchart JC, Auwerx J. An update on the mechanisms of action of the peroxisome proliferator-activated receptors PPAR-s and their roles in inflammol/Lation and cancer. Cell Mol Life Sci, 1999,5:32-43.
  • 9Oates JC, Reilly CM, Crosby MB, et al. Peroxisome Proliferator-Activated Receptor-γ Agonists Potential Use for Treating Chronic Inflammol/Latory Diseases. Arthritis Rheumatism, 2002 , 46 : 598-605 .

同被引文献14

  • 1Brush J, Lipnick SL, Phillips T, et al. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol, 2007, 17: 121- 130.
  • 2Nishioka A, Ogawa Y, Mima T. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-13) receptor mediated by adenoviral vector. Int J J Radiat Oncol Biol Phys, 2004,58:1235- 1241.
  • 3Han G, Zhou YF, Zhang MS. Angelica sinensis down-regulates hydroxyproline and TGF-β1 and provides protection in mice with radiation-induced pulmonary fibrosis. Radiat Res, 2006,165:546- 552.
  • 4Shek FW, Benyon RC. How can transforming growth factor beta be targeted usefully to combat liver fibrosis. Eur J Gastroenterol Hepato,2004,16 : 123-125.
  • 5Min AK, Kim MK, Seo HY, et al. Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-β signaling pathway. Biochem Biophys Res Commun, 2010, 393: 536-541.
  • 6Liu X, Wang W, Hu H, et al. Smad3 specific inhibitor, naringenin, decreeases the exp ression of extracelluar matrix induced by TGF-β1 in cultured rat hepatic stellate cells. Pharrn Res, 2006, 23:82-89.
  • 7Liu XJ, Ruan CM, Gong XF, et al. Antagonism of transforming groth factor beta signaling inhibits fibrosis-related genes. Biotechnol Lett ,2005,27 : 1609-1613.
  • 8Li MY, Deng H, Zhao JM. PPAR gamma pathway activation results in apoptosis and COX2-inhibition in Hep G-cells. World J Gastroenterol,2003,9 : 1220-1230.
  • 9Vamecq J, Latruffe N. Medical significance of peroxisome proliferentiator-activated receptors. Lancet, 1999,354 : 141-148.
  • 10Zheng F, Fomoni A, Eliot SJ. Upregulation of type I collagen by TGF-beta in mesangial ceils is blocked by PPAR gamma activation. Am J Physiol Renal Physiol,2002 ,282 :639-648.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部